Problems with PFJ implants with new recalls from Zimmer and DePuy

By

Revision rates prompt recalls for Johnson & Johnson’s DePuy Synthes, Zimmer Biomet (MassDevice)
High revision rates for orthopedic implants prompted recalls in recent months for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes and Zimmer Biomet (NYSE:ZBH).

Last month DePuy Synthes recalled a stand-alone element of its Sigma HP partial knee replacement, the Sigma HP PFJ cemented trochlear implant, “based on elevated revision rates observed as part of the company’s post-market surveillance process.” No other Sigma HP implant or total knee is implicated in the recall, J&J said...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.